Second Amendment to ADB’s Support to Enhance COVID-19 Vaccine Access

Institutional Document | May 2021

This paper proposes clarifications to the APVAX policy to ensure that ADB can flexibly meet DMC demands for vaccine support under a transparent and systematic framework while also providing adequate resources for non-COVID-19 operations.


  • Background
    • Rapid Response Component Country Ceilings and the Use of the Project Investment Component for COVID-19 Vaccine Procurement
    • ADB’s Resource Availability
    • Existing Approach to Financing COVID-19 Vaccine Procurement under APVAX
  • Proposed Clarifications and Amendments
  • Recommendation
  • Appendix

Additional Details

  • Health
  • Communicable and vector-borne diseases
  • Emerging diseases
  • COVID-19

Subscribe to our monthly digest of latest ADB publications.

Follow ADB Publications on social media.